Skip to main content
SpringerLink
Log in

Integrative Therapies for People with Chronic Obstructive Pulmonary Disease

  • Chapter
  • First Online:
Integrative Therapies in Lung Health and Sleep

Part of the book series: Respiratory Medicine ((RM,volume 4))

Abstract

Chronic obstructive pulmonary disease (COPD) is an inflammatory illness distinguished by irreversible airflow limitation. It includes a spectrum of obstructive lung diseases, especially chronic bronchitis and emphysema, and despite optimal medical and pharmacological therapy, most people with COPD continue to suffer from symptoms of chronic, progressive dyspnea, cough, and fatigue. Patients must manage these symptoms themselves or with the support of caregivers on a day-to-day basis. Therefore, many patients turn to complementary and alternative therapies (CAM) for symptom relief. The purpose of this chapter is to review a wide variety of CAM therapies that have been described or tested in patients with COPD, including body-based practices such as massage, mind–body and movement practices such as acupuncture/acupressure or yoga, natural products such as aromatics and supplements, and whole medical systems such as Ayurveda and Traditional Chinese Medicine. The current state of the science concerning most CAM therapies for patients with COPD consists of awareness of therapies that patients anecdotally report to be beneficial, and exploratory pilot studies to document safety and efficacy. Many patients choose to use CAM therapies without consulting their medical doctor. Consequently, it is important for conventional medical providers to educate themselves about CAM options and inquire about each patient’s CAM practices to ensure safety of the treatment regimen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fabbri L, Pauwels RA, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. COPD. 2004;1(1):105–41; discussion 103–4.

    Google Scholar 

  2. Celli BR. Update on the management of COPD. Chest. 2008;133(6):1451–62.

    PubMed  Google Scholar 

  3. Halpin DM, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc. 2006;3(7):619–23.

    PubMed  Google Scholar 

  4. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294(10):1255–9.

    PubMed  CAS  Google Scholar 

  5. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–413.

    PubMed  Google Scholar 

  6. Bausewein C, Booth S, Gysels M, Kuhnbach R, Haberland B, Higginson IJ. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med. 2010;13(9):1109–18.

    PubMed  Google Scholar 

  7. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care. 2003;1(4):337–44.

    PubMed  Google Scholar 

  8. George J, Ioannides-Demos LL, Santamaria NM, Kong DC, Stewart K. Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Med J Aust. 2004;181(5):248–51.

    PubMed  Google Scholar 

  9. NCCAM. What is complementary and alternative medicine? NCCAM Publication #D347; 2010.

    Google Scholar 

  10. Mason S, Tovey P, Long AF. Evaluating complementary medicine: methodological challenges of randomised controlled trials. BMJ. 2002;325(7368):832–4.

    PubMed  Google Scholar 

  11. Abadoglu O, Cakmak E, Kuzucu Demir S. The view of patients with asthma or chronic obstructive pulmonary disease (COPD) on complementary and alternative medicine. Allergol Immunopathol (Madr). 2008;36(1):21–5.

    CAS  Google Scholar 

  12. Testerman JK, Morton KR, Mason RA, Ronan AM. Patient motivations for using complementary and alternative medicine. Complement Health Pract Rev. 2004;9(2):81–92.

    Google Scholar 

  13. Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998;279(19):1548–53.

    PubMed  CAS  Google Scholar 

  14. Lewith GT. Respiratory illness: a complementary perspective. Thorax. 1998;53(10):898–904.

    PubMed  CAS  Google Scholar 

  15. Beeken JE, Parks D, Cory J, Montopoli G. The effectiveness of neuromuscular release massage therapy in five individuals with chronic obstructive lung disease. Clin Nurs Res. 1998;7(3):309–25.

    PubMed  CAS  Google Scholar 

  16. Roig M, Reid WD. Electrical stimulation and peripheral muscle function in COPD: a systematic review. Respir Med. 2009;103(4):485–95.

    PubMed  Google Scholar 

  17. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax. 2002;57(4):333–7.

    PubMed  CAS  Google Scholar 

  18. Bourjeily-Habr G, Rochester CL, Palermo F, Snyder P, Mohsenin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax. 2002;57(12):1045–9.

    PubMed  CAS  Google Scholar 

  19. Vivodtzev I, Pepin JL, Vottero G, et al. Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest. 2006;129(6):1540–8.

    PubMed  Google Scholar 

  20. Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest. 2003;124(1):292–6.

    PubMed  Google Scholar 

  21. Dal Corso S, Napolis L, Malaguti C, et al. Skeletal muscle structure and function in response to electrical stimulation in moderately impaired COPD patients. Respir Med. 2007;101(6):1236–43.

    PubMed  Google Scholar 

  22. Becklake MR, Mc GM, Goldman HI, Braudo JL. A study of the effects of physiotherapy in chronic hypertrophic emphysema using lung function tests. Dis Chest. 1954;26(2):180–91.

    PubMed  CAS  Google Scholar 

  23. Allen TW, Kelso AF. Osteopathic research and respiratory disease. J Am Osteopath Assoc. 1980;79(6):360.

    PubMed  CAS  Google Scholar 

  24. Howell RK, Kappler RE. The influence of osteopathic manipulative therapy on a patient with advanced cardiopulmonary disease. J Am Osteopath Assoc. 1973;73(4):322–7.

    PubMed  CAS  Google Scholar 

  25. Mall R. An evaluation of routine pulmonary function tests as indicators of responsiveness of a patient with chronic obstructive lung disease to osteopathic health care. J Am Osteopath Assoc. 1973;73(4):327–33.

    PubMed  CAS  Google Scholar 

  26. Masarsky CS, Weber M. Chiropractic management of chronic obstructive pulmonary disease. J Manipulative Physiol Ther. 1988;11(6):505–10.

    PubMed  CAS  Google Scholar 

  27. Engel RM, Vemulpad S. Progression to chronic obstructive pulmonary disease (COPD): could it be prevented by manual therapy and exercise during the “at risk” stage (stage 0)? Med Hypotheses. 2009;72(3):288–90.

    PubMed  Google Scholar 

  28. Engel RM, Vemulpad SR. Immediate effects of osteopathic manipulative treatment in elderly patients with chronic obstructive pulmonary disease. J Am Osteopath Assoc. 2008;108(10):541–2. author reply 542.

    PubMed  Google Scholar 

  29. Foellner RP, Taylor RM, Marjan G, Kelso AF. Proposed study to evaluate the effect of osteopathic manipulative therapy in the treatment of the emphysema patient. J Am Osteopath Assoc. 1968;67(9):1075–6.

    PubMed  CAS  Google Scholar 

  30. Kappler RE. A proposed cooperative study of osteopathic management of chronic obstructive lung disease. J Am Osteopath Assoc. 1970;69(10):1037–9.

    PubMed  CAS  Google Scholar 

  31. Noll DR, Degenhardt BF, Johnson JC, Burt SA. Immediate effects of osteopathic manipulative treatment in elderly patients with chronic obstructive pulmonary disease. J Am Osteopath Assoc. 2008;108(5):251–9.

    PubMed  Google Scholar 

  32. Howell RK, Allen TW, Kappler RE. The influence of osteopathic manipulative therapy in the management of patients with chronic obstructive lung disease. J Am Osteopath Assoc. 1975;74(8):757–60.

    PubMed  CAS  Google Scholar 

  33. Wilkinson IS, Prigmore S, Rayner CF. A randomised-controlled trail examining the effects of reflexology of patients with chronic obstructive pulmonary disease (COPD). Complement Ther Clin Pract. 2006;12(2):141–7.

    PubMed  Google Scholar 

  34. Jobst K, Chen JH, McPherson K, et al. Controlled trial of acupuncture for disabling breathlessness. Lancet. 1986;2(8521–22):1416–9.

    PubMed  CAS  Google Scholar 

  35. Lewith GT, Prescott P, Davis CL. Can a standardized acupuncture technique palliate disabling breathlessness: a single-blind, placebo-controlled crossover study. Chest. 2004;125(5):1783–90.

    PubMed  Google Scholar 

  36. Suzuki M, Namura K, Ohno Y, et al. The effect of acupuncture in the treatment of chronic obstructive pulmonary disease. J Altern Complement Med. 2008;14(9):1097–105.

    PubMed  Google Scholar 

  37. Wu HS, Lin LC, Wu SC, Lin JG. The psychologic consequences of chronic dyspnea in chronic pulmonary obstruction disease: the effects of acupressure on depression. J Altern Complement Med. 2007;13(2):253–61.

    PubMed  Google Scholar 

  38. Wu HS, Wu SC, Lin JG, Lin LC. Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease. J Adv Nurs. 2004;45(3):252–9.

    PubMed  Google Scholar 

  39. Maa SH, Gauthier D, Turner M. Acupressure as an adjunct to a pulmonary rehabilitation program. J Cardiopulm Rehabil. 1997;17(4):268–76.

    PubMed  CAS  Google Scholar 

  40. Maa SH, Sun MF, Hsu KH, et al. Effect of acupuncture or acupressure on quality of life of patients with chronic obstructive asthma: a pilot study. J Altern Complement Med. 2003;9(5):659–70.

    PubMed  Google Scholar 

  41. Maa SH, Tsou TS, Wang KY, Wang CH, Lin HC, Huang YH. Self-administered acupressure reduces the symptoms that limit daily activities in bronchiectasis patients: pilot study findings. J Clin Nurs. 2007;16(4):794–804.

    PubMed  Google Scholar 

  42. Lau KS, Jones AY. A single session of Acu-TENS increases FEV1 and reduces dyspnoea in patients with chronic obstructive pulmonary disease: a randomised, placebo-controlled trial. Aust J Physiother. 2008;54(3):179–84.

    PubMed  Google Scholar 

  43. Ngai SP, Jones AY, Hui-Chan CW, Ko FW, Hui DS. Effect of 4 weeks of Acu-TENS on functional capacity and beta-endorphin level in subjects with chronic obstructive pulmonary disease: a randomized controlled trial. Respir Physiol Neurobiol. 2010;173(1):29–36.

    PubMed  CAS  Google Scholar 

  44. von Riedenauer WB, Baker MK, Brewer RJ. Video-assisted thorascopic removal of migratory acupuncture needle causing pneumothorax. Chest. 2007;131(3):899–901.

    Google Scholar 

  45. Whale C, Hallam C. Tension pneumothorax related to acupuncture. Acupunct Med. 2004;22(2):101. author reply 101–2.

    PubMed  Google Scholar 

  46. Jobst KA. A critical analysis of acupuncture in pulmonary disease: efficacy and safety of the acupuncture needle. J Altern Complement Med. 1995;1(1):57–85.

    PubMed  CAS  Google Scholar 

  47. Jobst KA. Acupuncture in asthma and pulmonary disease: an analysis of efficacy and safety. J Altern Complement Med. 1996;2(1):179–206; discussion 110–207.

    Google Scholar 

  48. Giardino ND, Chan L, Borson S. Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: preliminary findings. Appl Psychophysiol Biofeedback. 2004;29(2):121–33.

    PubMed  Google Scholar 

  49. Sitzman J, Kamiya J, Johnston J. Biofeedback training for reduced respiratory rate in chronic obstructive pulmonary disease: a preliminary study. Nurs Res. 1983;32(4):218–23.

    PubMed  CAS  Google Scholar 

  50. Tiwary RS, Lakhera SC, Kain TC, Sinha KC. Effect of incentive breathing on lung functions in chronic obstructive pulmonary disease (COPD). J Assoc Physicians India. 1989;37(11):689–91.

    PubMed  CAS  Google Scholar 

  51. Collins EG, Langbein WE, Fehr L, et al. Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2008;177(8):844–52.

    PubMed  Google Scholar 

  52. Johnston R, Lee K. Myofeedback: a new method of teaching breathing exercises in emphysematous patients. Phys Ther. 1976;56(7):826–31.

    PubMed  CAS  Google Scholar 

  53. Gigliotti F, Romagnoli I, Scano G. Breathing retraining and exercise conditioning in patients with chronic obstructive pulmonary disease (COPD): a physiological approach. Respir Med. 2003;97(3):197–204.

    PubMed  CAS  Google Scholar 

  54. Engen RL. The singer’s breath: implications for treatment of persons with emphysema. J Music Ther. 2005;42(1):20–48.

    PubMed  Google Scholar 

  55. Gosselink R. Controlled breathing and dyspnea in patients with chronic obstructive pulmonary disease (COPD). J Rehabil Res Dev. 2003;40(5 Suppl 2):25–33.

    PubMed  Google Scholar 

  56. Jones AY, Dean E, Chow CC. Comparison of the oxygen cost of breathing exercises and spontaneous breathing in patients with stable chronic obstructive pulmonary disease. Phys Ther. 2003;83(5):424–31.

    PubMed  Google Scholar 

  57. de Andrade AD, Silva TN, Vasconcelos H, et al. Inspiratory muscular activation during threshold therapy in elderly healthy and patients with COPD. J Electromyogr Kinesiol. 2005;15(6):631–9.

    PubMed  Google Scholar 

  58. Koppers RJ, Vos PJ, Boot CR, Folgering HT. Exercise performance improves in patients with COPD due to respiratory muscle endurance training. Chest. 2006;129(4):886–92.

    PubMed  Google Scholar 

  59. Weiner P, McConnell A. Respiratory muscle training in chronic obstructive pulmonary disease: inspiratory, expiratory, or both? Curr Opin Pulm Med. 2005;11(2):140–4.

    PubMed  Google Scholar 

  60. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5 Suppl):4S–2.

    PubMed  Google Scholar 

  61. Lotters F, van Tol B, Kwakkel G, Gosselink R. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J. 2002;20(3):570–6.

    PubMed  CAS  Google Scholar 

  62. Breslin EH. The pattern of respiratory muscle recruitment during pursed-lip breathing. Chest. 1992;101(1):75–8.

    PubMed  CAS  Google Scholar 

  63. Faager G, Stahle A, Larsen FF. Influence of spontaneous pursed lips breathing on walking endurance and oxygen saturation in patients with moderate to severe chronic obstructive pulmonary disease. Clin Rehabil. 2008;22(8):675–83.

    PubMed  CAS  Google Scholar 

  64. Tiep BL, Burns M, Kao D, Madison R, Herrera J. Pursed lips breathing training using ear oximetry. Chest. 1986;90(2):218–21.

    PubMed  CAS  Google Scholar 

  65. Bianchi R, Gigliotti F, Romagnoli I, et al. Patterns of chest wall kinematics during volitional pursed-lip breathing in COPD at rest. Respir Med. 2007;101(7):1412–8.

    PubMed  Google Scholar 

  66. Nield MA, Soo Hoo GW, Roper JM, Santiago S. Efficacy of pursed-lips breathing: a breathing pattern retraining strategy for dyspnea reduction. J Cardiopulm Rehabil Prev. 2007;27(4):237–44.

    PubMed  Google Scholar 

  67. Cahalin LP, Braga M, Matsuo Y, Hernandez ED. Efficacy of diaphragmatic breathing in persons with chronic obstructive pulmonary disease: a review of the literature. J Cardiopulm Rehabil. 2002;22(1):7–21.

    PubMed  Google Scholar 

  68. Yan Q, Sun Y. Quantitative research for improving respiratory muscle contraction by breathing exercise. Chin Med J (Engl). 1996;109(10):771–5.

    CAS  Google Scholar 

  69. Campbell E, Friend J. Action of breathing exercises in pulmonary emphysema. Lancet. 1955;1:325–9.

    Google Scholar 

  70. Miller WF. A physiologic evaluation of the effects of diaphragmatic breathing training in patients with chronic pulmonary emphysema. Am J Med. 1954;17:471–7.

    PubMed  CAS  Google Scholar 

  71. Sackner MA, Gonzalez HF, Jenouri G, Rodriguez M. Effects of abdominal and thoracic breathing on breathing pattern components in normal subjects and in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1984;130(4):584–7.

    PubMed  CAS  Google Scholar 

  72. Willeput R, Vachaudez JP, Lenders D, Nys A, Knoops T, Sergysels R. Thoracoabdominal motion during chest physiotherapy in patients affected by chronic obstructive lung disease. Respiration. 1983;44(3):204–14.

    PubMed  CAS  Google Scholar 

  73. Delgado HR, Braun SR, Skatrud JB, Reddan WG, Pegelow DF. Chest wall and abdominal motion during exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1982;126(2):200–5.

    PubMed  CAS  Google Scholar 

  74. Sharma V. Diaphragmatic breathing training: further investigation needed. Phys Ther. 2005;85(4):366–7. author reply 367–8.

    PubMed  Google Scholar 

  75. Dechman G, Wilson CR. Evidence underlying breathing retraining in people with stable chronic obstructive pulmonary disease. Phys Ther. 2004;84(12):1189–97.

    PubMed  Google Scholar 

  76. Gosselink R. Breathing techniques in patients with chronic obstructive pulmonary disease (COPD). Chron Respir Dis. 2004;1(3):163–72.

    PubMed  CAS  Google Scholar 

  77. Lewis LK, Williams MT, Olds T. Short-term effects on outcomes related to the mechanism of intervention and physiological outcomes but insufficient evidence of clinical benefits for breathing control: a systematic review. Aust J Physiother. 2007;53(4):219–27.

    PubMed  Google Scholar 

  78. Vitacca M, Clini E, Bianchi L, Ambrosino N. Acute effects of deep diaphragmatic breathing in COPD patients with chronic respiratory insufficiency. Eur Respir J. 1998;11(2):408–15.

    PubMed  CAS  Google Scholar 

  79. Ferrari K, Goti P, Duranti R, et al. Breathlessness and control of breathing in patients with COPD. Monaldi Arch Chest Dis. 1997;52(1):18–23.

    PubMed  CAS  Google Scholar 

  80. Gallo-Silver L, Pollack B. Behavioral interventions for lung cancer-related breathlessness. Cancer Pract. 2000;8(6):268–73.

    PubMed  CAS  Google Scholar 

  81. Kawut SM, Mandel M, Arcasoy SM. Two faces of progressive dyspnea. Chest. 2000;117(5):1500–4.

    PubMed  CAS  Google Scholar 

  82. Gorini M, Misuri G, Corrado A, et al. Breathing pattern and carbon dioxide retention in severe chronic obstructive pulmonary disease. Thorax. 1996;51(7):677–83.

    PubMed  CAS  Google Scholar 

  83. Dudgeon DJ, Lertzman M, Askew GR. Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage. 2001;21(5):373–9.

    PubMed  CAS  Google Scholar 

  84. Gift AG, Cahill CA. Psychophysiologic aspects of dyspnea in chronic obstructive pulmonary disease: a pilot study. Heart Lung. 1990;19(3):252–7.

    PubMed  CAS  Google Scholar 

  85. Spahija J, de Marchie M, Grassino A. Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnea at rest and during exercise in COPD. Chest. 2005;128(2):640–50.

    PubMed  Google Scholar 

  86. Pomidori L, Campigotto F, Amatya TM, Bernardi L, Cogo A. Efficacy and tolerability of yoga breathing in patients with chronic obstructive pulmonary disease: a pilot study. J Cardiopulm Rehabil Prev. 2009;29(2):133–7.

    PubMed  Google Scholar 

  87. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J. 2010;35(3):676–80.

    PubMed  CAS  Google Scholar 

  88. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:967–75.

    PubMed  CAS  Google Scholar 

  89. O’Donnell DE, McGuire M, Samis L, Webb KA. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med. 1995;152:2005–13.

    PubMed  Google Scholar 

  90. O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(5):770–7.

    PubMed  Google Scholar 

  91. Collins E, Fehr L, Bammert C, et al. Effect of ventilation-feedback training on endurance and perceived breathlessness during constant work-rate leg-cycle exercise in patients with COPD. J Rehabil Res Dev. 2003;40(5 Suppl 2):35–44.

    PubMed  Google Scholar 

  92. Sharma V. Personal communication; 2004.

    Google Scholar 

  93. Frownfelter D, Massery M. Facilitating ventilation patterns and breathing strategies. In: Frownfelter D, Dean E, editors. Cardiovascular and pulmonary physical therapy: evidence and practice. 4th ed. St. Louis: Mosby; 2006. p. 377–404.

    Google Scholar 

  94. Carrieri-Kohlman V. Dyspnea in the weaning patient: assessment and intervention. AACN Clin Issues Crit Care Nurs. 1991;2(3):462–73.

    PubMed  CAS  Google Scholar 

  95. Petty TL, Burns M, Tiep BL. Essentials of pulmonary rehabilitation: a do it yourself guide to enjoying life with chronic lung disease. 2nd ed. http://www.perf2ndwind.org/Essentials.html; 2005.

  96. Chauhan AJ, McLindon JP, Dillon P, Sawyer JP, Gray L, Leahy BC. Regular balloon inflation for patients with chronic bronchitis: a randomised controlled trial. BMJ. 1992;304(6843):1668–9.

    PubMed  CAS  Google Scholar 

  97. Kurabayashi H, Machida I, Handa H, Akiba T, Kubota K. Comparison of three protocols for breathing exercises during immersion in 38 degrees C water for chronic obstructive pulmonary disease. Am J Phys Med Rehabil. 1998;77(2):145–8.

    PubMed  CAS  Google Scholar 

  98. Izumizaki M, Kakizaki F, Tanaka K, Homma I. Immediate effects of thixotropy conditioning of inspiratory muscles on chest-wall volume in chronic obstructive pulmonary disease. Respir Care. 2006;51(7):750–7.

    PubMed  Google Scholar 

  99. Bonilha AG, Onofre F, Vieira ML, Prado MY, Martinez JA. Effects of singing classes on pulmonary function and quality of life of COPD patients. Int J Chron Obstruct Pulmon Dis. 2009;4:1–8.

    PubMed  Google Scholar 

  100. Lord VM, Cave P, Hume VJ, et al. Singing teaching as a therapy for chronic respiratory disease—a randomised controlled trial and qualitative evaluation. BMC Pulm Med. 2010;10:41.

    PubMed  Google Scholar 

  101. Hendricks G. Conscious breathing: breathwork for health, stress release and personal mastery. New York: Bantan Books; 1995.

    Google Scholar 

  102. Lewis D. Free your breath, free your life: how conscious breathing can relieve stress, increase vitality, and help you live more fully. Boston: Shambhala Publications; 2004.

    Google Scholar 

  103. Carrieri V, Janson-Bjerklie S. Strategies patients use to manage the sensation of dyspnea. West J Nurs Res. 1986;8:284–305.

    PubMed  CAS  Google Scholar 

  104. Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987;136(1):58–61.

    PubMed  CAS  Google Scholar 

  105. Galbraith S, Perkins P, Lynch A, Booth S. Does a handheld fan improve intractable breathlessness? Proceedings of the EAPC research forum. Trondheim, Norway; 2008.

    Google Scholar 

  106. Bausewein C, Booth S, Gysels M, Kuhnbach R, Higginson IJ. Effectiveness of a hand-held fan for breathlessness: a randomized phase II trial. BMC Palliat Care. 2010;9:22.

    PubMed  Google Scholar 

  107. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage. 2010;39(5):831–8.

    PubMed  Google Scholar 

  108. Hansen-Flaschen J. Advanced lung disease: palliation and terminal care. Clin Chest Med. 1997;18(3):645–55.

    PubMed  CAS  Google Scholar 

  109. Moody LE, Fraser M, Yarandi H. Effects of guided imagery in patients with chronic bronchitis and emphysema. Clin Nurs Res. 1993;2(4):478–86.

    PubMed  CAS  Google Scholar 

  110. Louie SW. The effects of guided imagery relaxation in people with COPD. Occup Ther Int. 2004;11(3):145–59.

    PubMed  Google Scholar 

  111. Kurabayashi H, Kubota K, Machida I, Tamura K, Take H, Shirakura T. Effective physical therapy for chronic obstructive pulmonary disease. Pilot study of exercise in hot spring water. Am J Phys Med Rehabil. 1997;76(3):204–7.

    PubMed  CAS  Google Scholar 

  112. Kurabayashi H, Machida I, Tamura K, Iwai F, Tamura J, Kubota K. Breathing out into water during subtotal immersion: a therapy for chronic pulmonary emphysema. Am J Phys Med Rehabil. 2000;79(2):150–3.

    PubMed  CAS  Google Scholar 

  113. Perk J, Perk L, Boden C. Cardiorespiratory adaptation of COPD patients to physical training on land and in water. Eur Respir J. 1996;9(2):248–52.

    PubMed  CAS  Google Scholar 

  114. Wadell K, Sundelin G, Henriksson-Larsen K, Lundgren R. High intensity physical group training in water—an effective training modality for patients with COPD. Respir Med. 2004;98(5):428–38.

    PubMed  Google Scholar 

  115. Acosta-Austan F. Tolerance of chronic dyspnea using a hypnoeducational approach: a case report. Am J Clin Hypn. 1991;33(4):272–7.

    PubMed  CAS  Google Scholar 

  116. Acosta F. Weaning the anxious ventilator patient using hypnotic relaxation: case reports. Am J Clin Hypn. 1987;29(4):272–80.

    PubMed  CAS  Google Scholar 

  117. Sato P, Sargur M, Schoene RB. Hypnosis effect on carbon dioxide chemosensitivity. Chest. 1986;89(6):828–31.

    PubMed  CAS  Google Scholar 

  118. Brutsche MH, Grossman P, Muller RE, et al. Impact of laughter on air trapping in severe chronic obstructive lung disease. Int J Chron Obstruct Pulmon Dis. 2008;3(1):185–92.

    PubMed  Google Scholar 

  119. Lebowitz KR. The effects of humor on cardiopulmonary functioning, psychological well-being, and health status among older adults with chronic obstructive pulmonary disease. Department of Psychology, Ohio State University; 2002.

    Google Scholar 

  120. Ludwig DS, Kabat-Zinn J. Mindfulness in medicine. JAMA. 2008;300(11):1350–2.

    PubMed  CAS  Google Scholar 

  121. Chiesa A, Serretti A. Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. Psychiatry Res. 2011;187(3):441–53.

    PubMed  Google Scholar 

  122. Mularski RA, Munjas BA, Lorenz KA, et al. Randomized controlled trial of mindfulness-based therapy for dyspnea in chronic obstructive lung disease. J Altern Complement Med. 2009;15(10):1083–90.

    PubMed  Google Scholar 

  123. Bauldoff GS, Hoffman LA, Zullo TG, Sciurba FC. Exercise maintenance following pulmonary rehabilitation: effect of distractive stimuli. Chest. 2002;122(3):948–54.

    PubMed  Google Scholar 

  124. Bauldoff GS, Rittinger M, Nelson T, Doehrel J, Diaz PT. Feasibility of distractive auditory stimuli on upper extremity training in persons with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005;25(1):50–5.

    PubMed  Google Scholar 

  125. Thornby MA, Haas F, Axen K. Effect of distractive auditory stimuli on exercise tolerance in patients with COPD. Chest. 1995;107(5):1213–7.

    PubMed  CAS  Google Scholar 

  126. von Leupoldt A, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B. Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD. Chest. 2007;132(5):1506–12.

    Google Scholar 

  127. McBride S, Graydon J, Sidani S, Hall L. The therapeutic use of music for dyspnea and anxiety in patients with COPD who live at home. J Holist Nurs. 1999;17(3):229–50.

    PubMed  CAS  Google Scholar 

  128. Singh VP, Rao V, Prem V, Sahoo RC, Keshev Pai K. Comparison of the effectiveness of music and progressive muscle relaxation for anxiety in COPD—a randomized controlled pilot study. Chron Respir Dis. 2009;6(4):209–16.

    PubMed  Google Scholar 

  129. Brooks D, Sidani S, Graydon J, McBride S, Hall L, Weinacht K. Evaluating the effects of music on dyspnea during exercise in individuals with chronic obstructive pulmonary disease: a pilot study. Rehabil Nurs. 2003;28(6):192–6.

    PubMed  Google Scholar 

  130. Pfister T, Berrol C, Caplan C. Effects of music on exercise and perceived symptoms in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 1998;18(3):228–32.

    PubMed  CAS  Google Scholar 

  131. Bauldoff GS. Music: more than just a melody. Chron Respir Dis. 2009;6(4):195–7.

    PubMed  CAS  Google Scholar 

  132. Sharp JT, Drutz WS, Moisan T, et al. Postural relief of dyspnea in severe chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980;122:201–13.

    PubMed  CAS  Google Scholar 

  133. Barach AL. Chronic obstructive lung disease: postural relief of dyspnea. Arch Phys Med Rehabil. 1974;55(11):494–504.

    PubMed  CAS  Google Scholar 

  134. O’Neill S, McCarthy DS. Postural relief of dyspnoea in severe chronic airflow limitation: relationship to respiratory muscle strength. Thorax. 1983;38(8):595–600.

    PubMed  Google Scholar 

  135. Landers MR, McWhorter JW, Filibeck D, Robinson C. Does sitting posture in chronic obstructive pulmonary disease really matter? An analysis of 2 sitting postures and their effect [corrected] on pulmonary function. J Cardiopulm Rehabil. 2006;26(6):405–9.

    PubMed  Google Scholar 

  136. McKeough ZJ, Alison JA, Bye PT. Arm positioning alters lung volumes in subjects with COPD and healthy subjects. Aust J Physiother. 2003;49(2):133–7.

    PubMed  Google Scholar 

  137. Cavalheri V, Camillo CA, Brunetto AF, Probst VS, Ramos EM, Pitta F. Effects of arm bracing posture on respiratory muscle strength and pulmonary function in patients with chronic obstructive pulmonary disease. Rev Port Pneumol. 2010;16(6):887–91.

    PubMed  CAS  Google Scholar 

  138. Honeyman P, Barr P, Stubbing DG. Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation. J Cardiopulm Rehabil. 1996;16(1):63–7.

    PubMed  CAS  Google Scholar 

  139. Probst VS, Troosters T, Coosemans I, et al. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest. 2004;126(4):1102–7.

    PubMed  Google Scholar 

  140. Solway S, Brooks D, Lau L, Goldstein R. The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD. Chest. 2002;122(1):56–65.

    PubMed  Google Scholar 

  141. Renfroe KL. Effect of progressive relaxation on dyspnea and state anxiety in patients with chronic obstructive pulmonary disease. Heart Lung. 1988;17(4):408–13.

    PubMed  CAS  Google Scholar 

  142. Gift AG, Moore T, Soeken K. Relaxation to reduce dyspnea and anxiety in COPD patients. Nurs Res. 1992;41(4):242–6.

    PubMed  CAS  Google Scholar 

  143. Lolak S, Connors GL, Sheridan MJ, Wise TN. Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychother Psychosom. 2008;77(2):119–25.

    PubMed  Google Scholar 

  144. Broussard R. Using relaxation for COPD. Am J Nurs. 1979;79(11):1962–3.

    PubMed  CAS  Google Scholar 

  145. Fujimoto K, Kubo K, Miyahara T, et al. Effects of muscle relaxation therapy using specially designed plates in patients with pulmonary emphysema. Intern Med. 1996;35(10):756–63.

    PubMed  CAS  Google Scholar 

  146. Wang C, Bannuru R, Ramel J, Kupelnick B, Scott T, Schmid CH. Tai Chi on psychological well-being: systematic review and meta-analysis. BMC Complement Altern Med. 2010;10:23.

    PubMed  Google Scholar 

  147. Yeh GY, Roberts DH, Wayne PM, Davis RB, Quilty MT, Phillips RS. Tai chi exercise for patients with chronic obstructive pulmonary disease: a pilot study. Respir Care. 2010;55(11):1475–82.

    PubMed  Google Scholar 

  148. Cavanaugh C. Beyond relaxation: the work of Milton Trager. Yoga J. 1982;46(5):20–5.

    Google Scholar 

  149. Witt PL, MacKinnon J. Trager psychophysical integration. A method to improve chest mobility of patients with chronic lung disease. Phys Ther. 1986;66(2):214–7.

    PubMed  CAS  Google Scholar 

  150. Carrieri-Kohlman V, Gormley JM, Douglas MK, Paul SM, Stulbarg MS. Exercise training decreases dyspnea and the distress and anxiety associated with it. Monitoring alone may be as effective as coaching. Chest. 1996;110(6):1526–35.

    PubMed  CAS  Google Scholar 

  151. Kidd P, Parshall MB, Wojcik S, Struttmann T. Assessing recalibration as a response-shift phenomenon. Nurs Res. 2004;53(2):130–5.

    PubMed  Google Scholar 

  152. Wilson IB. Clinical understanding and clinical implications of response shift. In: Schwartz CE, Sprangers MAG, editors. Adaptation to changing health: response shift in quality-of-life research. Washington: American Psychological Association; 2000. p. 159–74.

    Google Scholar 

  153. Behera D. Yoga therapy in chronic bronchitis. J Assoc Physicians India. 1998;46(2):207–8.

    PubMed  CAS  Google Scholar 

  154. Donesky-Cuenco D, Nguyen HQ, Paul S, Carrieri-Kohlman V. Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. J Altern Complement Med. 2009;15(3):225–34.

    PubMed  Google Scholar 

  155. Tandon MK. Adjunct treatment with yoga in chronic severe airways obstruction. Thorax. 1978;33(4):514–7.

    PubMed  CAS  Google Scholar 

  156. Pomidori L, Campigotto F, Amatya TM, Bernardi L, Cogo A. Efficacy and tolerability of yoga breathing in patients with chronic obstructive pulmonary disease: a pilot study. J Cardiopulm Rehabil Prev. 2009;29(2):133–7.

    PubMed  Google Scholar 

  157. Kulpati DD, Kamath RK, Chauhan MR. The influence of physical conditioning by yogasanas and breathing exercises in patients of chronic obstructive lung disease. J Assoc Physicians India. 1982;30(12):865–8.

    PubMed  CAS  Google Scholar 

  158. Hasani A, Pavia D, Toms N, Dilworth P, Agnew JE. Effect of aromatics on lung mucociliary clearance in patients with chronic airways obstruction. J Altern Complement Med. 2003;9(2):243–9.

    PubMed  Google Scholar 

  159. Agacdiken A, Basyigit I, Ozden M, et al. The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology. 2004;9(1):38–42.

    PubMed  Google Scholar 

  160. Rahman I, Kilty I. Antioxidant therapeutic targets in COPD. Curr Drug Targets. 2006;7(6):707–20.

    PubMed  CAS  Google Scholar 

  161. Rautalahti M, Virtamo J, Haukka J, et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. Am J Respir Crit Care Med. 1997;156(5):1447–52.

    PubMed  CAS  Google Scholar 

  162. Ochs-Balcom HM, Grant BJ, Muti P, et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr. 2006;60(8):991–9.

    PubMed  CAS  Google Scholar 

  163. Tug T, Karatas F, Terzi SM. Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease. Clin Invest Med. 2004;27(3):123–8.

    PubMed  CAS  Google Scholar 

  164. Devereux G, Seaton A. Why don’t we give chest patients dietary advice? Thorax. 2001;56 Suppl 2:ii15–22.

    PubMed  Google Scholar 

  165. Tabak C, Smit HA, Rasanen L, et al. Dietary factors and pulmonary function: a cross sectional study in middle aged men from three European countries. Thorax. 1999;54(11):1021–6.

    PubMed  CAS  Google Scholar 

  166. Miedema I, Feskens EJ, Heederik D, Kromhout D. Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study. Am J Epidemiol. 1993;138(1):37–45.

    PubMed  CAS  Google Scholar 

  167. Walda IC, Tabak C, Smit HA, et al. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries. Eur J Clin Nutr. 2002;56(7):638–43.

    PubMed  CAS  Google Scholar 

  168. Wu TC, Huang YC, Hsu SY, Wang YC, Yeh SL. Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease. Int J Vitam Nutr Res. 2007;77(4):272–9.

    PubMed  CAS  Google Scholar 

  169. Sargeant LA, Jaeckel A, Wareham NJ. Interaction of vitamin C with the relation between smoking and obstructive airways disease in EPIC Norfolk. European prospective investigation into cancer and nutrition. Eur Respir J. 2000;16(3):397–403.

    PubMed  CAS  Google Scholar 

  170. Forli L, Pedersen JI, Bjortuft O, Blomhoff R, Kofstad J, Boe J. Vitamins A and E in serum in relation to weight and lung function in patients with advanced pulmonary disease. Int J Vitam Nutr Res. 2002;72(6):360–8.

    PubMed  CAS  Google Scholar 

  171. Nadeem A, Raj HG, Chhabra SK. Effect of vitamin E supplementation with standard treatment on oxidant-antioxidant status in chronic obstructive pulmonary disease. Indian J Med Res. 2008;128(6):705–11.

    PubMed  CAS  Google Scholar 

  172. Daga MK, Chhabra R, Sharma B, Mishra TK. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci. 2003;28(1):7–11.

    PubMed  CAS  Google Scholar 

  173. Menzel DB. Antioxidant vitamins and prevention of lung disease. Ann N Y Acad Sci. 1992;669:141–55.

    PubMed  CAS  Google Scholar 

  174. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol. 2000;151(10):975–81.

    PubMed  CAS  Google Scholar 

  175. Gumral N, Naziroglu M, Ongel K, et al. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods. Cell Biochem Funct. 2009;27(5):276–83.

    PubMed  CAS  Google Scholar 

  176. Jindal SK. Does vitamin E supplementation help in COPD? Indian J Med Res. 2008;128(6):686–7.

    PubMed  CAS  Google Scholar 

  177. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets. Curr Drug Targets Inflamm Allergy. 2002;1(3):291–315.

    PubMed  CAS  Google Scholar 

  178. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis. 2008;2(6):351–74.

    PubMed  Google Scholar 

  179. Tanrikulu AC, Abakay A, Evliyaoglu O, Palanci Y. Coenzyme Q10, copper, zinc, and lipid peroxidation levels in serum of patients with chronic obstructive pulmonary disease. Biol Trace Elem Res. 2011;143:659–67.

    PubMed  CAS  Google Scholar 

  180. Fujimoto S, Kurihara N, Hirata K, Takeda T. Effects of coenzyme Q10 administration on pulmonary function and exercise performance in patients with chronic lung diseases. Clin Investig. 1993;71(8 Suppl):S162–6.

    PubMed  CAS  Google Scholar 

  181. Wada H, Hagiwara S, Saitoh E, et al. Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) as measured by redox status of plasma coenzyme Q10. Pathophysiology. 2006;13(1):29–33.

    PubMed  CAS  Google Scholar 

  182. Satta A, Grandi M, Landoni CV, et al. Effects of ubidecarenone in an exercise training program for patients with chronic obstructive pulmonary diseases. Clin Ther. 1991;13(6):754–7.

    PubMed  CAS  Google Scholar 

  183. Mancini A, Corbo GM, Gaballo A, et al. Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. Biofactors. 2005;25(1–4):201–4.

    PubMed  CAS  Google Scholar 

  184. Andersson I, Gronberg A, Slinde F, Bosaeus I, Larsson S. Vitamin and mineral status in elderly patients with chronic obstructive pulmonary disease. Clin Respir J. 2007;1(1):23–9.

    PubMed  CAS  Google Scholar 

  185. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009;179(8):630–6.

    PubMed  CAS  Google Scholar 

  186. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exp Immunol. 2009;158(1):20–5.

    PubMed  CAS  Google Scholar 

  187. Gilbert CR, Arum SM, Smith CM. Vitamin D deficiency and chronic lung disease. Can Respir J. 2009;16(3):75–80.

    PubMed  Google Scholar 

  188. Fimognari FL, Loffredo L, Di Simone S, et al. Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease. Nutr Metab Cardiovasc Dis. 2009;19(9):654–9.

    PubMed  CAS  Google Scholar 

  189. Villaca DS, Lerario MC, Dal Corso S, Neder JA. New treatments for chronic obstructive pulmonary disease using ergogenic aids. J Bras Pneumol. 2006;32(1):66–74.

    PubMed  Google Scholar 

  190. Deacon SJ, Vincent EE, Greenhaff PL, et al. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(3):233–9.

    PubMed  CAS  Google Scholar 

  191. Faager G, Soderlund K, Skold CM, Rundgren S, Tollback A, Jakobsson P. Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study. Int J Chron Obstruct Pulmon Dis. 2006;1(4):445–53.

    PubMed  CAS  Google Scholar 

  192. Fuld JP, Kilduff LP, Neder JA, et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax. 2005;60(7):531–7.

    PubMed  CAS  Google Scholar 

  193. Al-Ghimlas F, Todd DC. Creatine supplementation for patients with COPD receiving pulmonary rehabilitation: a systematic review and meta-analysis. Respirology. 2010;15(5):785–95.

    PubMed  Google Scholar 

  194. Griffiths TL, Proud D. Creatine supplementation as an exercise performance enhancer for patients with COPD? An idea to run with. Thorax. 2005;60(7):525–6.

    PubMed  CAS  Google Scholar 

  195. Borghi-Silva A, Baldissera V, Sampaio LM, et al. l-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs. Braz J Med Biol Res. 2006;39(4):465–74.

    PubMed  CAS  Google Scholar 

  196. Shilo L, Dagan Y, Smorjik Y, et al. Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int. 2000;17(1):71–6.

    PubMed  CAS  Google Scholar 

  197. Nunes DM, Mota RM, Machado MO, Pereira ED, Bruin VM, Bruin PF. Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease. Braz J Med Biol Res. 2008;41(10):926–31.

    PubMed  CAS  Google Scholar 

  198. Koning CJ, Jonkers D, Smidt H, et al. The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics. Br J Nutr. 2009;103(10):1452–60.

    PubMed  Google Scholar 

  199. Kutsuzawa T, Shioya S, Kurita D, Haida M, Ohta Y, Yamabayashi H. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance study. Am J Respir Crit Care Med. 1995;152(2):647–52.

    PubMed  CAS  Google Scholar 

  200. Sridhar MK, Carter R, Lean ME, Banham SW. Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty. Thorax. 1994;49(8):781–5.

    PubMed  CAS  Google Scholar 

  201. Keim NL, Luby MH, Braun SR, Martin AM, Dixon RM. Dietary evaluation of outpatients with chronic obstructive pulmonary disease. J Am Diet Assoc. 1986;86(7):902–6.

    PubMed  CAS  Google Scholar 

  202. Gronberg AM, Slinde F, Engstrom CP, Hulthen L, Larsson S. Dietary problems in patients with severe chronic obstructive pulmonary disease. J Hum Nutr Diet. 2005;18(6):445–52.

    PubMed  CAS  Google Scholar 

  203. Slinde F, Gronberg AM, Engstrom CR, Rossander-Hulthen L, Larsson S. Individual dietary intervention in patients with COPD during multidisciplinary rehabilitation. Respir Med. 2002;96(5):330–6.

    PubMed  CAS  Google Scholar 

  204. Brug J, Schols A, Mesters I. Dietary change, nutrition education and chronic obstructive pulmonary disease. Patient Educ Couns. 2004;52(3):249–57.

    PubMed  Google Scholar 

  205. Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl. 2003;46:81s–6.

    PubMed  CAS  Google Scholar 

  206. Kubo H, Honda N, Tsuji F, Iwanaga T, Muraki M, Tohda Y. Effects of dietary supplements on the Fischer ratio before and after pulmonary rehabilitation. Asia Pac J Clin Nutr. 2006;15(4):551–5.

    PubMed  CAS  Google Scholar 

  207. Hirayama F, Lee AH, Binns CW, Taniguchi H. Dietary supplementation by Japanese patients with chronic obstructive pulmonary disease. Complement Ther Med. 2009;17(1):37–43.

    PubMed  Google Scholar 

  208. Celik F, Topcu F. Nutritional risk factors for the development of chronic obstructive pulmonary disease (COPD) in male smokers. Clin Nutr. 2006;25(6):955–61.

    PubMed  Google Scholar 

  209. Strachan DP, Cox BD, Erzinclioglu SW, Walters DE, Whichelow MJ. Ventilatory function and winter fresh fruit consumption in a random sample of British adults. Thorax. 1991;46(9):624–9.

    PubMed  CAS  Google Scholar 

  210. Cerda B, Soto C, Albaladejo MD, et al. Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2006;60(2):245–53.

    PubMed  CAS  Google Scholar 

  211. Lin YC, Wu TC, Chen PY, Hsieh LY, Yeh SL. Comparison of plasma and intake levels of antioxidant nutrients in patients with chronic obstructive pulmonary disease and healthy people in Taiwan: a case-control study. Asia Pac J Clin Nutr. 2010;19(3):393–401.

    PubMed  CAS  Google Scholar 

  212. Rahman I. Antioxidant therapies in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):15–29.

    PubMed  CAS  Google Scholar 

  213. Sartor L, Pezzato E, Garbisa S. (−)Epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema, and invasion. J Leukoc Biol. 2002;71(1):73–9.

    PubMed  CAS  Google Scholar 

  214. Venkatesan N, Punithavathi D, Babu M. Protection from acute and chronic lung diseases by curcumin. Adv Exp Med Biol. 2007;595:379–405.

    PubMed  Google Scholar 

  215. Schwartz J, Weiss ST. The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Survey (NHANES I). Eur Respir J. 1994;7(10):1821–4.

    PubMed  CAS  Google Scholar 

  216. Shahar E, Folsom AR, Melnick SL, et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med. 1994;331(4):228–33.

    PubMed  CAS  Google Scholar 

  217. Sharp DS, Rodriguez BL, Shahar E, Hwang LJ, Burchfiel CM. Fish consumption may limit the damage of smoking on the lung. Am J Respir Crit Care Med. 1994;150(4):983–7.

    PubMed  CAS  Google Scholar 

  218. Matsuyama W, Mitsuyama H, Watanabe M, et al. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. Chest. 2005;128(6):3817–27.

    PubMed  CAS  Google Scholar 

  219. Ram A, Balachandar S, Vijayananth P, Singh VP. Medicinal plants useful for treating chronic obstructive pulmonary disease (COPD): current status and future perspectives. Fitoterapia. 2011;82(2):141–51.

    PubMed  Google Scholar 

  220. Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of COPD: a systematic review. Eur Respir J. 2006;28(2):330–8.

    PubMed  CAS  Google Scholar 

  221. A.D.A.M. Inc. What is traditional Chinese medicine? http://www.umm.edu/altmed/articles/traditional-chinese-000363.htm

  222. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61(15):2163–75.

    PubMed  CAS  Google Scholar 

  223. Shen ZY, Jiang XH, Zha LL, et al. Studies on the use of warming kidney regime in senile chronic bronchitis. J Tradit Chin Med. 1983;3(4):295–302.

    PubMed  CAS  Google Scholar 

  224. Liu Y, Wang N, Liu G, Yan H. Clinical observation in 31 cases of chronic bronchitis at remission stage treated with bufei keli. J Tradit Chin Med. 2003;23(4):246–50.

    PubMed  Google Scholar 

  225. Zhu Y, Liu X. Treatment of chronic bronchitis with modified ma xing shi gan tang and er chen tang. J Tradit Chin Med. 2004;24(1):12–3.

    PubMed  Google Scholar 

  226. Wang G, Li TQ, Mao B, et al. Relationship between bone mineral density and syndrome types described in traditional Chinese medicine in chronic obstructive pulmonary disease: a preliminary clinical observation. Am J Chin Med. 2005;33(6):867–77.

    PubMed  Google Scholar 

  227. Zhong Y, Mao B, Wang G, et al. Tanreqing injection combined with conventional Western medicine for acute exacerbations of chronic obstructive pulmonary disease: a systematic review. J Altern Complement Med. 2010;16(12):1309–19.

    PubMed  Google Scholar 

  228. Gross D, Shenkman Z, Bleiberg B, Dayan M, Gittelson M, Efrat R. Ginseng improves pulmonary functions and exercise capacity in patients with COPD. Monaldi Arch Chest Dis. 2002;57(5–6):242–6.

    PubMed  CAS  Google Scholar 

  229. Shinozuka N, Tatsumi K, Nakamura A, Terada J, Kuriyama T. The traditional herbal medicine Hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2007;55(2):313–4.

    PubMed  Google Scholar 

  230. Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial. Explore (NY). 2005;1(6):437–45.

    CAS  Google Scholar 

  231. Matthys H, Heger M. EPs 7630-solution—an effective therapeutic option in acute and exacerbating bronchitis. Phytomedicine. 2007;14 Suppl 6:65–8.

    PubMed  Google Scholar 

  232. Murali PM, Rajasekaran S, Paramesh P, et al. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study. Respir Med. 2006;100(1):39–45.

    PubMed  CAS  Google Scholar 

  233. Balamugesh T. Plant-based formulation in COPD. Respir Med. 2006;100(7):1294. author reply 1295.

    PubMed  CAS  Google Scholar 

  234. Rantzsch U, Vacca G, Duck R, Gillissen A. Anti-inflammatory effects of myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease. Eur J Med Res. 2009;14(4):205–9.

    PubMed  Google Scholar 

  235. Matthys H, de Mey C, Carls C, Rys A, Geib A, Wittig T. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung. 2000;50(8):700–11.

    PubMed  CAS  Google Scholar 

  236. Meister R, Wittig T, Beuscher N, de Mey C. Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators. Arzneimittelforschung. 1999;49(4):351–8.

    PubMed  CAS  Google Scholar 

  237. Ulmer WT, Schott D. Chronic obstructive bronchitis. Effect of Gelomyrtol forte in a placebo-controlled double-blind study. Fortschr Med. 1991;109(27):547–50.

    PubMed  CAS  Google Scholar 

  238. Sadlon AE, Lamson DW. Immune-modifying and antimicrobial effects of eucalyptus oil and simple inhalation devices. Altern Med Rev. 2010;15(1):33–47.

    PubMed  Google Scholar 

  239. Worth H, Schacher C, Dethlefsen U. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Respir Res. 2009;10:69.

    PubMed  Google Scholar 

  240. Hsu CL, Wu YL, Tang GJ, Lee TS, Kou YR. Ginkgo biloba extract confers protection from cigarette smoke extract-induced apoptosis in human lung endothelial cells: role of heme oxygenase-1. Pulm Pharmacol Ther. 2009;22(4):286–96.

    PubMed  CAS  Google Scholar 

  241. Babayigit A, Olmez D, Karaman O, et al. Effects of Ginkgo biloba on airway histology in a mouse model of chronic asthma. Allergy Asthma Proc. 2009;30(2):186–91.

    PubMed  Google Scholar 

  242. Haines DD, Varga B, Bak I, et al. Summative interaction between astaxanthin, Ginkgo biloba extract (EGb761) and vitamin C in suppression of respiratory inflammation: a comparison with ibuprofen. Phytother Res. 2011;25(1):128–36.

    PubMed  CAS  Google Scholar 

  243. Tang Y, Xu Y, Xiong S, et al. The effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patients. J Huazhong Univ Sci Technolog Med Sci. 2007;27(4):375–80.

    PubMed  CAS  Google Scholar 

  244. Shih CH, Huang TJ, Chen CM, Lin YL, Ko WC. S-petasin, the main sesquiterpene of Petasites formosanus. Inhibits phosphodiesterase activity and suppresses ovalbumin-induced airway hyperresponsiveness. Evid Based Complement Alternat Med. 2009;29:29.

    Google Scholar 

  245. Ziolo G, Samochowiec L. Study on clinical properties and mechanisms of action of Petasites in bronchial asthma and chronic obstructive bronchitis. Pharm Acta Helv. 1998;72(6):378–80.

    PubMed  CAS  Google Scholar 

  246. Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008;16(2):CD005623.

    Google Scholar 

  247. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003;327(7429):1459–61.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiological Nursing, University of California, 2 Koret Way, N631K, San Francisco, CA, 94143-0610, USA

    DorAnne M. Donesky PhD, RN

Authors
  1. DorAnne M. Donesky PhD, RN
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to DorAnne M. Donesky PhD, RN .

Editor information

Editors and Affiliations

  1. , School of Nursing, University of Minnesota, 308 Harvard St. SE, Minneapolis, 55455, Minnesota, USA

    Linda Chlan

  2. , Department of Pulmonary, Allergy, and Cr, University of Minnesota, 401 East River Road, Minneapolis, 55455, Minnesota, USA

    Marshall I. Hertz

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Donesky, D.M. (2012). Integrative Therapies for People with Chronic Obstructive Pulmonary Disease. In: Chlan, L., Hertz, M. (eds) Integrative Therapies in Lung Health and Sleep. Respiratory Medicine, vol 4. Humana Press. https://doi.org/10.1007/978-1-61779-579-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-579-4_4

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-578-7

  • Online ISBN: 978-1-61779-579-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation